| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Revenue | $1.12B | +11.5% |
| R&D Expense | $67.6M | +3.3% |
| SG&A Expense | $354.3M | +1.2% |
| Operating Income | $27.2M | +2067.5% |
| Interest Expense | $35.8M | +8.1% |
| Pre-tax Income | -$10.1M | +76.6% |
| Income Tax | -$1.5M | +78.0% |
| Net Income | -$8.6M | +76.3% |
| EPS (Basic) | -$0.12 | +78.6% |
| EPS (Diluted) | -$0.12 | +78.6% |
| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.1M | -48.0% |
| Accounts Receivable | $48.2M | -8.4% |
| Inventory | $314.6M | +49.1% |
| Current Assets | $412.7M | +21.6% |
| Total Assets | $1.65B | +7.3% |
| Current Liabilities | $167.9M | +10.6% |
| Long-term Debt | $496.8M | +10.6% |
| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.1M | +24.1% |
| Capital Expenditures | $21.5M | +114.8% |
| Investing Cash Flow | -$52.6M | -40.6% |
| Financing Cash Flow | $57.5M | +80.6% |
| Free Cash Flow | -$44.6M | -10.3% |
| Total Liabilities |
| $895.4M |
| +13.0% |
| Stockholders' Equity | $757.2M | +1.2% |